top of page
Search
Advancing AI-Driven Innovation in Pharma, Biotech, and MedTech —— Reflections on Completing the MIT Sloan Executive Program
SaniMed Science Group shares insights following Founder Jim Wu, M.D., MBA’s completion of the MIT Sloan Executive Program in Artificial Intelligence in Pharma and Biotech. The program deepened strategic understanding of AI-driven discovery, clinical development, regulatory readiness, and commercialization, reinforcing SaniMed’s mission to accelerate global MedTech and Biotech innovation across the U.S., China, and Europe through responsible, scalable AI solutions.
Nov 17, 20252 min read
SaniMed Science Group Founder Jim Wu Joins Bullpen Inviting You to Co-Build a New Platform for Cross-Border Healthcare Innovation
Jim Wu, M.D., MBA, Founder of SaniMed Science Group and Chairman of BioTech (Shanghai), has joined the U.S.-based Bullpen Club as a Lifetime Founder Member and Money Ball Program Coach. Leveraging nearly 30 years of experience in biotech, MedTech, AI healthcare, and cross-border investment, he will help connect Chinese and Asian healthcare innovators with global capital, strategic partners, and international acceleration platforms to advance global commercialization and colla
Nov 8, 20253 min read
Rochester Mayor Presents DMC’s $6 Billion Investment Plan in Shanghai — BioTech Ignites a New Engine for U.S.–China Health Collaboration!
At the 2025 U.S.–China Forum on Health Innovation and Collaboration in Shanghai, Rochester Mayor Kim Norton presented DMC’s US $6 billion health-innovation project, while BioTech (Shanghai) and SaniMed Science Group led discussions on AI, FDA readiness, and global expansion—strengthening U.S.–China partnerships and empowering Chinese MedTech firms to enter the U.S. market.
Nov 3, 20253 min read
BioTech (Shanghai) Participates in the 2025 Heartland Connect for Trade & Investment Conference!Exploring Long-Term Collaboration with Mayo-Linked DMC to Advance Global Health Innovation
BioTech (Shanghai) Chairman Jim Wu attended the 2025 Heartland Connect for Trade & Investment Conference, hosted by USHCA, engaging leaders from Mayo Clinic’s DMC and U.S. healthcare organizations. The event fostered dialogue on AI, healthcare access, and innovation, advancing U.S.–China collaboration and helping Chinese MedTech firms enter the American market.
Oct 16, 20253 min read
Breaking News: SaniMed Partners with Former Medtronic Executive Gary Carruthers to Lead Asian MedTech Companies Into a New Era of U.S. Market Expansion!
SaniMed Science Group (USA) has partnered with Gary Carruthers, former Medtronic executive and GI technology expert, as Market Advisor to guide Asian—especially Chinese—MedTech firms in R&D, FDA approval, and market entry. Together with BioTech (Shanghai), SaniMed is building a dual-platform to help Chinese innovators truly enter the U.S. healthcare market.
Jun 5, 20253 min read
bottom of page